Audrius Dulskas1, Alfredas Kilius2, Kestutis Petrulis2, Narimantas E Samalavicius2,3. 1. Department of General and Abdominal Surgery and Oncology, National Cancer Institute, 1 Santariskiu Str, LT-08406, Vilnius, Lithuania. audrius.dulskas@gmail.com. 2. Department of General and Abdominal Surgery and Oncology, National Cancer Institute, 1 Santariskiu Str, LT-08406, Vilnius, Lithuania. 3. Departament of Surgical oncology, National Cancer Institute, Vilnius University, Clinic of Internal, Family Medicine and Oncology, Faculty of Medicine, Vilnius, Lithuania.
Abstract
PURPOSE: The purpose of this study is to look at our early postoperative results, recurrence rates and need for further radical surgery in treating large (> 5 cm) rectal tumours by transanal endoscopic microsurgery (TEM). METHODS: Patients who underwent TEM for rectal tumours greater than 5 cm were included. Tumour diameter was determined based on fresh specimen measurements. We recorded the demographics, operative details, final pathology, length of hospital stay, complications and recurrence rates. RESULTS: Mean tumour size was 5.9 ± 1.5 cm. 68.4% of tumours (13/19) were in the middle part of the rectum. Three patients (15.8%) developed postoperative complications: two had postoperative bleeding (10.5%), one had wound dehiscence (5.3%). Three patients had involved margins (15.8%). After a median follow up of 25.2 months, there were two recurrences (10.5%). One patient developed rectal cancer 6 years after removal of rectal adenoma. CONCLUSION: TEM is feasible and safe for the treatment of giant benign rectal tumours. It may be an alternative method for proctectomy in selected patients.
PURPOSE: The purpose of this study is to look at our early postoperative results, recurrence rates and need for further radical surgery in treating large (> 5 cm) rectal tumours by transanal endoscopic microsurgery (TEM). METHODS:Patients who underwent TEM for rectal tumours greater than 5 cm were included. Tumour diameter was determined based on fresh specimen measurements. We recorded the demographics, operative details, final pathology, length of hospital stay, complications and recurrence rates. RESULTS: Mean tumour size was 5.9 ± 1.5 cm. 68.4% of tumours (13/19) were in the middle part of the rectum. Three patients (15.8%) developed postoperative complications: two had postoperative bleeding (10.5%), one had wound dehiscence (5.3%). Three patients had involved margins (15.8%). After a median follow up of 25.2 months, there were two recurrences (10.5%). One patient developed rectal cancer 6 years after removal of rectal adenoma. CONCLUSION: TEM is feasible and safe for the treatment of giant benign rectal tumours. It may be an alternative method for proctectomy in selected patients.
Authors: Cillian Clancy; John P Burke; Mathew R Albert; P Ronan O'Connell; Desmond C Winter Journal: Dis Colon Rectum Date: 2015-02 Impact factor: 4.585
Authors: R M Barendse; F J C van den Broek; J van Schooten; W A Bemelman; P Fockens; E J R de Graaf; E Dekker Journal: Colorectal Dis Date: 2012-04 Impact factor: 3.788
Authors: C Luigiano; P Consolo; M G Scaffidi; G Strangio; G Giacobbe; A Alibrandi; S Pallio; A Tortora; G Melita; L Familiari Journal: Endoscopy Date: 2009-09-11 Impact factor: 10.093